HemoTypeSC Has a CE Mark and is Registered in India, Ghana, Nigeria, Kenya, and Saudi Arabia

Impact




"New sickle cell disease testing on Nigerian newborns"

According to the study, 3,603 children younger than nine months were screened using HemoTypeSC to show the feasibility of adding newborn screening into existing primary health-care immunizations with rapid testing. This reinforces access to patients with sickle cell in poor communities, a shift from developed countries with better nutrition, bigger financial budgets, and infectious disease vaccines having prominent accessibility, according to the Fogarty International Center at the National Institutes of Health.

Read More

"A 10-minute test could solve Africa’s sickle cell disease screening problem for newborns"

The integration of newborn screening into existing primary healthcare immunization programs is feasible and can rapidly be implemented with limited resources, according to a study led by professor Obiageli Nnodu, director of the Centre of Excellence for Sickle Cell Disease Research and Training at Nigeria’s University of Abuja.  To realistically screen every newborn for sickle cell disease, Nnodu says a simple, reliable and affordable point-of-care rapid test will be deployed at immunization clinics, a place most newborns will visit soon after birth. One such example is the HemoTypeSC) from Silver Lake Research, a diagnostics firm based in southern California.

Read More

"Advocacy for the construction of a sickle cell anemia care center in Côte d'Ivoire"

The various hematology departments of the three university hospital centers in Côte d'Ivoire recorded in 2014, 11,972 patients suffering from sickle cell anemia, including 8,572 in Yopougon, 3,000 in Cocody and 400 in Treichville, with an average of 600 new cases each year.  Patrice Sékongo, country director of the European Institute for Cooperation and Development, called for mass screening and improved patient care thanks to a preventive system that is operational.  In a presentation on the evolution of screening tools, Dr Yao Atimeré, a hematologist, presented the HemoTypeSC test, which can detect sickle cell anemia in ten minutes. A solution that comes to save lives.

Read More
Television News Coverage of Accuracy+Feasibility Validation Study Workshop

Television News Coverage of Accuracy+Feasibility Validation Study Workshop

Read More

"Good news for Ivorian people. Now, they can know their hemoglobin status..."

Good news for Ivorian people. Now, they can know their hemoglobin status thanks to the HemoTypeSC test, a rapid process for screening for sickle cell disease that has performed well in several African countries...Eugène Aka-Aouélé, Minister of Health and Dr. ADOUENI Katché Valéry, Coordinating Director of the National Program for Metabolic Diseases and NCD Prevention, have stated that the new process will enable Ivory Coast to take a step forward in the fight against sickle cell disease.  He welcomed the researchers who conducted the study that led to the establishment of the HemoTypeSC.
Read More

"Rapid Result Test On Track to Transform Sickle Cell Disease Screening for Millions"

May 08, 2019

"Now, research shows that with a new rapid result test kit, a diagnosis of sickle cell disease may no longer be a death sentence for children in the most affected parts of the world. HemoTypeSC, a dipstick-type test, is relatively inexpensive, accurate, and can provide timely diagnosis of sickle cell disease, according to the study published in the American Journal of Hematology. The test has the potential to be a game-changer for people with the disease who live in distressed areas around the world."
Read More

"$2 Test Could Transform Sickle Cell Dx in Africa"

" 'HemoTypeSC is an accurate, inexpensive, and rapid tool that can enable sickle cell disease screening programs across rural areas of Africa and India, where it's not being screened for at all,' - late-breaking abstract press briefing at the American Society of Hematology meeting."

Read More

"New Sickle Cell Test Can Transform Screening"

  
 "A new test that costs less than $2, requires only a small drop of blood, and can be performed in about 10 minutes could dramatically change the dynamics of sickle cell diagnosis in Africa, say researchers who developed the product."
Read More

HemoTypeSC Presented in Late-Breaking Abstract

"A trial in Uganda showed a new test called HemoTypeSCTM was more than 99 percent accurate in detecting sickle cell disease in young children. The test requires only a small drop of blood and returns results in about 10 minutes, making it suitable for routine screening of newborns."
Read More

Pre-Release Press Conference to Discuss Uganda Validation Study Data

 
"If [HemoTypeSC] were to be widely implemented in newborn screening initiatives in sub-Saharan Africa and India, it could significantly reduce the mortality of the disease when combined with both treatment and counseling. This would potentially save millions of lives over several decades."
Read More

ASH Clinical News Interview - HemoTypeSC Late-Breaking Abstract

Erik Serrao discusses the data from a recently-completed field validation trial in southeastern Uganda.  In this collaboration with the Sickle Cell Association of Uganda, led by Ruth Nankanja, HemoTypeSC correctly identified the hemoglobin type of 1,000 out of 1,000 children screened.

Read More

Lack of Funds Hinders Govt’s Policy on SCD

December 13, 2018

Dr. Alayo Sopekan, National Desk Officer, Ministry of Health, said: “Nigeria has the highest burden of Sickle Cell Disease (SCD) in the world ahead of Democratic Republic of Congo and India.”  He called for early diagnosis and treatment of the disease.

Read More

Nigerian Health Ministry Introduces POC Testing

January 30, 2018

Video: Nigerian officials reveal how the country loses over 150,000 newborns to sickle cell disease every year. OakTV presents a report on the accuracy of HemoTypeSC™, a 10 minute investigational test kit. 

Read More

Experts Advocate Newborn Screening for Sickle Cell

January 30, 2018

Video: Professor Obiageli Nnodu, sickle cell disease expert from the University of Abuja, describes the current status of sickle cell disease in Nigeria and the results from early testing with HemoTypeSC™.

Read More